BSE Live
Dec 26, 16:01Prev. Close
424.45
Open Price
422.25
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 26, 15:59Prev. Close
422.00
Open Price
420.05
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
417.30 (4)
| Key Financial Ratios of Aarti Drugs (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 21.53 | 12.85 | 11.17 | 10.91 | 10.86 | |
| Diluted EPS (Rs.) | 21.53 | 12.85 | 11.17 | 10.91 | 10.86 | |
| Cash EPS (Rs.) | 32.69 | 22.31 | 20.34 | 19.22 | 18.58 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 116.52 | 102.48 | 93.14 | 84.08 | 74.54 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 116.52 | 102.48 | 93.14 | 84.08 | 74.54 | |
| Dividend / Share(Rs.) | 5.00 | 3.00 | 1.80 | 1.20 | 1.50 | |
| Revenue from Operations/Share (Rs.) | 389.33 | 321.56 | 265.38 | 241.29 | 215.91 | |
| PBDIT/Share (Rs.) | 59.53 | 48.60 | 33.57 | 29.46 | 26.86 | |
| PBIT/Share (Rs.) | 48.36 | 39.17 | 25.34 | 22.10 | 20.09 | |
| PBT/Share (Rs.) | 36.19 | 19.77 | 15.23 | 13.68 | 12.90 | |
| Net Profit/Share (Rs.) | 21.53 | 12.85 | 11.17 | 10.91 | 10.86 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 15.29 | 15.11 | 12.64 | 12.21 | 12.43 | |
| PBIT Margin (%) | 12.42 | 12.18 | 9.54 | 9.16 | 9.30 | |
| PBT Margin (%) | 9.29 | 6.14 | 5.73 | 5.66 | 5.97 | |
| Net Profit Margin (%) | 5.52 | 3.99 | 4.20 | 4.52 | 5.02 | |
| Return on Networth / Equity (%) | 18.47 | 12.53 | 11.98 | 12.97 | 14.56 | |
| Return on Capital Employed (%) | 7.69 | 4.76 | 3.97 | 4.21 | 4.53 | |
| Return on Assets (%) | 6.38 | 3.89 | 3.30 | 3.55 | 3.70 | |
| Total Debt/Equity (X) | 1.26 | 1.49 | 1.88 | 1.96 | 2.09 | |
| Asset Turnover Ratio (%) | 115.39 | 97.40 | 78.65 | 78.75 | 73.63 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 2.86 | 2.61 | 2.83 | 3.10 | 2.71 | |
| Quick Ratio (X) | 2.02 | 1.81 | 1.90 | 2.07 | 1.72 | |
| Inventory Turnover Ratio (X) | 8.05 | 6.58 | 5.05 | 4.94 | 4.04 | |
| Dividend Payout Ratio (NP) (%) | 23.22 | 23.35 | 16.12 | 11.00 | 13.81 | |
| Dividend Payout Ratio (CP) (%) | 15.29 | 13.44 | 8.84 | 6.24 | 8.07 | |
| Earnings Retention Ratio (%) | 76.78 | 76.65 | 83.88 | 89.00 | 86.19 | |
| Cash Earnings Retention Ratio (%) | 84.71 | 86.56 | 91.16 | 93.76 | 91.93 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 297.68 | 220.27 | 263.95 | 261.02 | 279.80 | |
| EV/Net Operating Revenue (X) | 0.63 | 0.59 | 0.85 | 0.92 | 1.11 | |
| EV/EBITDA (X) | 4.13 | 3.87 | 6.72 | 7.57 | 8.90 | |
| MarketCap/Net Operating Revenue (X) | 0.26 | 0.12 | 0.20 | 0.26 | 0.41 | |
| Retention Ratios (%) | 76.77 | 76.64 | 83.87 | 88.99 | 86.18 | |
| Price/BV (X) | 0.88 | 0.37 | 0.56 | 0.74 | 1.19 | |
| Price/Net Operating Revenue | 0.26 | 0.12 | 0.20 | 0.26 | 0.41 | |
| Earnings Yield | 0.21 | 0.34 | 0.21 | 0.18 | 0.12 |
14.11.2025
Aarti Drugs Consolidated September 2025 Net Sales at Rs 652.79 crore, up 9.1% Y-o-Y
12.11.2025
Aarti Drugs Standalone September 2025 Net Sales at Rs 578.95 crore, up 6.6% Y-o-Y
18.07.2025
Aarti Drugs Standalone June 2025 Net Sales at Rs 520.96 crore, up 5.68% Y-o-Y
18.07.2025
Aarti Drugs Consolidated June 2025 Net Sales at Rs 590.51 crore, up 6.33% Y-o-Y